作者: Darren Williams , Da-Woon Jung , Woong-Hee Kim
DOI:
关键词:
摘要: The present invention relates to ENOblock, which is a non-substrate analogue having an enolase inhibitory activity, and pharmaceutical composition for preventing or treating cancer enolase-associated diseases, containing the same. ENOblock of directly binds so as inhibit activity thereof, inhibition more effective in hypoxia than normoxia. In addition, inhibits migration, metastasis invasion cells. Furthermore, induces glucose uptake into cells, down-regulates expression PEPCK, adipogenesis foam cell formation. Therefore, can be very effectively applied prevent treat diseases.